Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice. van Leuven SI, Mendez-Fernandez YV, Wilhelm AJ, Wade NS, Gabriel CL, Kastelein JJ, Stroes ES, Tak PP, Major AS (2012) Ann Rheum Dis 71: 408-14 Lupus nephritis: treatment with mycophenolate mofetil. Kapitsinou PP, Boletis JN, Skopouli FN, Boki KA, Moutsopoulos HM (2004) Rheumatology (Oxford) 43: 377-80 Outcomes with conversion from calcineurin inhibitors to sirolimus after renal transplantation in the context of steroid withdrawal or steroid continuation. Egbuna OI, Davis RB, Chudinski R, Pavlakis M, Rogers C, Molakatalla P, Johnson SR, Karp S, Monaco AP, Tang H, Hanto DW, Mandelbrot DA (2009) Transplantation 88: 684-92 Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients. Bolin P, Tanriover B, Zibari GB, Lynn ML, Pirsch JD, Chan L, Cooper M, Langone AJ, Tomlanovich SJ (2007) Transplantation 84: 1443-51 Enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients experiencing gastrointestinal intolerance: a multicenter, double-blind, randomized study. Langone AJ, Chan L, Bolin P, Cooper M (2011) Transplantation 91: 470-8 Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failure. Pechman KR, Basile DP, Lund H, Mattson DL (2008) Am J Physiol Regul Integr Comp Physiol 294: R1234-9 Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry. Langone A, Doria C, Greenstein S, Narayanan M, Ueda K, Sankari B, Pankewycz O, Shihab F, Chan L (2013) Clin Transplant 27: 15-24 A pilot protocol of a calcineurin-inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function. Shaffer D, Langone A, Nylander WA, Goral S, Kizilisik AT, Helderman JH (2003) Clin Transplant 17 Suppl 9: 31-4 Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies. Pawate S, Wang L, Song Y, Sriram S (2012) J Neuroimaging 22: 137-44 Calcineurin inhibitor avoidance versus steroid avoidance following kidney transplantation: Postoperative complications. Shaffer D, Kizilisik AT, Feurer I, Nylander WA, Helderman JH, Langone AJ, Schaefer HM (2006) Transplant Proc 38: 3464-5 Short-term results under three different immunosuppressive regimens at one center. Schaefer HM, Kizilisik AT, Feurer I, Nylander WA, Langone AJ, Helderman JH, Shaffer D (2006) Transplant Proc 38: 3466-7
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.